BMO Capital Maintains Market Perform on Livent, Lowers Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Joel Jackson has maintained a 'Market Perform' rating on Livent (NYSE:LTHM) but lowered the price target from $24 to $20.
November 01, 2023 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BMO Capital has maintained its 'Market Perform' rating on Livent but lowered the price target from $24 to $20, which could impact investor sentiment.
The lowering of the price target by BMO Capital from $24 to $20 indicates a less optimistic outlook for Livent's stock. This could potentially lead to a negative sentiment among investors, possibly causing a short-term decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100